Sat 5/25/2019 05:39 ET
S&P 5002826.063.960.14%BANKS433.274.851.12%OIL59.001.091.85%BITCOIN8011.5115.220.19%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Penny Stocks (Pressure BioSciences - PBIO)   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add PBIO
From: NetworkNewsWire (Rep: 0)Date: 11/20/2018 17:26
Forum: Penny Stocks - Msg #2429 - List PBIO msgs Thread #674048924 (Rec: 0)
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) President and CEO Featured in Uptick Newswire’s Stock Day Podcast

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences industry, this morning announced the featured interview of its president and CEO Richard T. Schumacher with Stock Day’s Everett Jolly. Among other highlights, Schumacher announced that the company has accomplished yet another important milestone in the advancement of its proprietary Ultra Shear Technology (“UST”) platform and commercialization program. Following the company’s recent news regarding the development of the first working prototype of the UST system, PBIO reported that it has developed a proprietary method for making high quality, water-soluble oils. The company believes that this achievement will open major new opportunities in multiple markets, including the CBD sector, and will result in revenue generation in 2019.

“There are multiple products in many different markets that we believe can benefit from nanoemulsions made by UST. These markets include but are certainly not limited to, food and beverages, cosmetics, pharmaceuticals, nutraceuticals, industrial lubricants, paints, and personal care products such as sunscreens. However, because of the excellent data generated to date, the clear need for water-soluble CBD oil, its current rapid and exciting growth, and the potential to generate a strong return for our shareholders, we have chosen to focus first on the CBD market. That said, we plan to keep a very keen eye on the other markets as well,” Pressure BioSciences president and CEO Richard T. Schumacher stated in the interview.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser NetworkNewsWire: Reward | Watch | IgnorePBIO: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add PBIO | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999-, Inc.